SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-052224
Filing Date
2023-10-05
Accepted
2023-10-05 17:19:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 impl_424b5_20231005.htm 424B5 533472
2 GRAPHIC img92553560_0.jpg GRAPHIC 60533
3 GRAPHIC img92553560_1.jpg GRAPHIC 37356
  Complete submission text file 0000950170-23-052224.txt   669632
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 424B5 | Act: 33 | File No.: 333-264987 | Film No.: 231312168
SIC: 2834 Pharmaceutical Preparations